Ptc Therapeutics (PTCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2018 | 06-2018 | 03-2018 | 12-2017 | 09-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 206,913 | 223,788 | 97,675 | 111,792 | 141,838 |
| Marketable Securities | 42,491 | 72,318 | 80,595 | 79,454 | 27,472 |
| Receivables | 42,197 | 59,383 | 45,611 | 40,394 | 38,744 |
| Inventories | 13,660 | 13,852 | 12,355 | 10,754 | 7,792 |
| TOTAL | $313,281 | $375,646 | $241,996 | $249,063 | $221,259 |
| Non-Current Assets | |||||
| PPE Net | 8,805 | 8,217 | 8,302 | 8,376 | 6,882 |
| Intangibles | 704,921 | 126,290 | 127,565 | 132,993 | 138,422 |
| Other Non-Current Assets | 1,620 | 1,620 | 1,548 | 1,221 | 1,157 |
| TOTAL | $715,346 | $136,127 | $137,415 | $142,590 | $146,461 |
| Total Assets | $1,028,627 | $511,773 | $379,411 | $391,653 | $367,720 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 6,667 | 1,666 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 102,788 | 82,534 | 71,437 | 76,446 | 64,054 |
| Other current liabilities | 3,463 | 2,274 | 1,279 | 1,665 | 1,723 |
| TOTAL | $114,922 | $86,474 | $72,716 | $82,048 | $71,899 |
| Non-Current Liabilities | |||||
| Long Term Debt | 144,258 | 147,204 | 146,878 | 144,971 | 143,091 |
| Deferred Revenues | 2,004 | N/A | N/A | 3,937 | 6,122 |
| Other Non-Current Liabilities | 218,801 | 153 | 209 | 243 | 269 |
| TOTAL | $527,615 | $157,897 | $156,387 | $153,168 | $149,939 |
| Total Liabilities | $642,537 | $244,371 | $229,103 | $235,216 | $221,838 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 50,455 | 46,714 | 46,446 | 41,796 | 41,490 |
| Common Shares | 51 | 47 | 42 | 42 | 41 |
| Retained earnings | -890,593 | -839,624 | -830,105 | -814,108 | -815,378 |
| Other shareholders' equity | 1,628 | 1,855 | 4,953 | 3,969 | 3,013 |
| TOTAL | $386,090 | $267,402 | $150,308 | $156,437 | $145,882 |
| Total Liabilities And Equity | $1,028,627 | $511,773 | $379,411 | $391,653 | $367,720 |